Ebola: un premier vaccin efficace à 100%, selon un essai sur le terrain
Le vaccin expérimental développé au Canada a été testé sur le terrain en Guinée sur plus de 4000 personnes....
- SUR LE MEME SUJET
(Reuters) - The U.S. Department of Health and Human Services (HHS) said on Wednesday it will fund the manufacturing of Merck & Co Inc’s investigational Ebola vaccine called V920, in response to the outbreak of the deadly virus in the Democratic Republic of the Congo (DRC). The Ebola hemorrhagic fever has killed at least 1,900 people in Congo over the past year, the second biggest death toll in the disease’s history, after a 2014-16 outbreak in West Africa that killed 11,300 people. The agency said it will give $23 million to Merck to... ...
NAIROBI (Reuters) - Burundi has started vaccinating its health workers against Ebola, beginning with those near the border with the Democratic Republic of Congo, the World Health Organization (WHO) said on Wednesday. Burundi has had no reported cases of the deadly haemorrhagic fever, but the viral disease has been spreading in eastern Congo since August 2018 in an epidemic that has now killed at least 1,800 people. Efforts to control the outbreak have been hampered by militia violence and some local resistance to outside help. The WHO sa... ...
FILE PHOTO: A young woman reacts as a health worker injects her with the Ebola vaccine, in Goma, Democratic Republic of Congo, August 5, 2019. REUTERS/Baz Ratner/File Photo GOMA (Reuters) - The World Health Organisation has vaccinated over 1,300 people who potentially came into contact with the Ebola virus in the Congolese city of Goma, it said on Sunday, helping contain what many feared would be a rapid spread in an urban center. A year-long Ebola outbreak in eastern Democratic Republic of Congo has killed at least 1,800, the second ... ...
LONDON (Reuters) - British drugmaker GlaxoSmithKline (GSK.L) is giving up its work on developing three potential vaccines against the deadly Ebola and Marburg viruses, despite an ongoing Ebola outbreak in Democratic Republic of Congo. FILE PHOTO: A young woman reacts as a health worker injects her with the Ebola vaccine, in Goma, Democratic Republic of Congo, August 5, 2019. REUTERS/Baz Ratner/File Photo While Ebola is a deadly and contagious disease, it is also still relatively rare, making the potential market for a vaccine sporadic ... ...
Un vaccin fabriqué par l'entreprise Johnson&Johnson est actuellement en test en Ouganda. Il pourrait être utilisé dans la République Démocratique du Congo (RDC) voisine, où une épidémie d'Ebola a fait plus de 1.800 morts en un an. L'essai du vaccin MVA-BN fabriqué par la société américaine Johnson&Johnson devrait durer deux ans, a indiqué le Conseil de recherche médicale (MRC) de l'Ouganda dans un communiqué. Le vaccin concernera jusqu'à 800 professionnels de la santé et personnels se trouvant en première ligne... ...
LONDON (Reuters) - British drugmaker GlaxoSmithKline is handing over all its development work on three potential vaccines against the deadly Ebola and Marburg viruses despite an ongoing Ebola outbreak in Democratic Republic of Congo. FILE PHOTO: The GlaxoSmithKline (GSK) logo is seen on top of GSK Asia House in Singapore, March 21, 2018. REUTERS/Loriene Perera The vaccine candidates - two designed to protect against Ebola and one against the Marburg virus - will be transferred to the Sabin Vaccine Institute in Washington, D.C., GSK sai... ...
GOMA, Democratic Republic of Congo (Reuters) - The resignation of Congo’s health minister in the midst of the country’s worst Ebola outbreak could clear the way for a second experimental vaccine to be deployed. But the new shot would likely take months to win the trust of frightened locals and show results, health officials say. FILE PHOTO: A Congolese health worker administers ebola vaccine to a child at the Himbi Health Centre in Goma, Democratic Republic of Congo, July 17, 2019. REUTERS/Olivia Acland/File Photo Oly Ilunga, who o... ...
GOMA, Democratic Republic of Congo (Reuters) - Congo’s health minister resigned on Monday after being stripped of responsibility for managing the country’s Ebola outbreak, potentially paving the way for the introduction of a second vaccine to contain the spreading epidemic. FILE PHOTO: A Congolese health worker administers Ebola vaccine to a child at the Himbi Health Centre in Goma, Democratic Republic of Congo, July 17, 2019. REUTERS/Olivia Acland Oly Ilunga has overseen Democratic Republic of Congo’s near year-long response t... ...
Le vaccin contre la grippe - administré par voie intramusculaire - n’est pas efficace à 100 %. Pour améliorer ces résultats, des chercheurs Inserm ont testé la voie cutanée. Leurs observations sont... ...
Le vaccin contre la grippe – administré par voie intramusculaire – n’est pas efficace à 100%. Pour améliorer ces résultats, des chercheurs Inserm ont testé la voie cutanée. Leurs observations sont encourageantes. Le vaccin antigrippal est le meilleur moyen pour prévenir la maladie et réduire le risque de complications graves, voire de décès. Pour autant, […] L’article Vaccin contre la grippe : plus efficace par voie cutanée ? est apparu en premier sur Destination Santé. ...
